Jan Basile to Drug Therapy, Combination
This is a "connection" page, showing publications Jan Basile has written about Drug Therapy, Combination.
Connection Strength
0.714
-
Recent clinical trials. J Am Soc Hypertens. 2014 Oct; 8(10):770-4; quiz 775-6.
Score: 0.103
-
Comparison of aliskiren/hydrochlorothiazide combination therapy with hydrochlorothiazide monotherapy in older patients with stage 2 systolic hypertension: results of the ACTION study. J Clin Hypertens (Greenwich). 2011 Mar; 13(3):162-9.
Score: 0.081
-
Combination angiotensin receptor blocker-neutral endopeptidase inhibitor provides additive blood pressure reduction over angiotensin receptor blocker alone. J Clin Hypertens (Greenwich). 2010 Oct; 12(10):809-12.
Score: 0.078
-
Lessons learned from the ONTARGET and TRANSCEND trials. Curr Atheroscler Rep. 2009 Sep; 11(5):371-6.
Score: 0.073
-
Rationale for fixed-dose combination therapy to reach lower blood pressure goals. South Med J. 2008 Sep; 101(9):918-24.
Score: 0.068
-
Shifting paradigms in defining and treating hypertension: addressing global risk with combination therapy. J Clin Hypertens (Greenwich). 2008 Jan; 10(1 Suppl 1):2-3.
Score: 0.065
-
Fixed-dose combination therapy in the treatment of hypertension: ready for prime time. South Med J. 2007 Apr; 100(4):343-4.
Score: 0.062
-
Beta-blockers for treatment of hypertension. Postgrad Med. 2003 Dec; 114(6 Suppl Role):11-7.
Score: 0.049
-
Halting the progression of heart failure: finding the optimal combination therapy. Cleve Clin J Med. 2002 Feb; 69(2):104-5, 109-10, 112.
Score: 0.043
-
Aspirin and angiotensin-converting enzyme inhibitors are safe when taken together after acute myocardial infarction in patients with left ventricular dysfunction. J Clin Hypertens (Greenwich). 2001 Nov-Dec; 3(6):376-7.
Score: 0.043
-
Cardiovascular Outcomes According to Systolic Blood Pressure in Patients With and Without Diabetes: An ACCOMPLISH Substudy. J Clin Hypertens (Greenwich). 2016 Apr; 18(4):299-307.
Score: 0.029
-
Combination therapy in hypertension. J Am Soc Hypertens. 2010 Jan-Feb; 4(1):42-50.
Score: 0.019